Spark Biomedical has been awarded funding from The Missed Vital Sign, Wellcome Leap’s $50 million program in women’s…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsHigh blood pressure may have no effect on acute TTP recovery
There appears to be no link between high blood pressure in the first two days after an acute episode of…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsHigh LDH may signal mortality risk in immune-mediated TTP
High levels of lactate dehydrogenase (LDH) in the blood — a sign that tissues and organs may have been damaged…
IMMUNE THROMBOCYTOPENIA
NewsDoptelet, Doptelet Sprinkle for pediatric ITP win FDA approval
Sobi’s Doptelet (avatrombopag), which is available as a tablet and an oral granule called Doptelet Sprinkle, is now approved…
IMMUNE THROMBOCYTOPENIA
NewsHetrombopag is safe, effective for ITP in real-world settings: Study
Hetrombopag appears to be a safe and effective option in real-world settings for immune thrombocytopenia (ITP), with better outcomes…